Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.
Adtalem Global Education Inc. (NYSE: ATGE) is a for-profit operator of colleges, universities, and professional schools with a strong focus on healthcare education. Company news frequently highlights its role as the largest or leading provider of healthcare education in the United States, as well as developments across its institutions, including Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
On this news page, readers can follow Adtalem’s announcements on academic and financial performance, such as quarterly and annual results, enrollment trends, and segment updates for Chamberlain, Walden, and the Medical and Veterinary segment. The company regularly issues releases on total student enrollment, revenue growth, and guidance for upcoming fiscal years, along with information about capital allocation, including share repurchase programs and debt reduction activities.
Adtalem’s news flow also covers strategic initiatives that shape its educational offerings. Examples include partnerships with health systems to fund nursing education and create employment pathways, international and domestic pathway programs into medical school, and collaborations that link medical education with data analytics and AI-focused curricula. The company has announced a strategic partnership with Google Cloud to launch an AI credentials program for healthcare professionals and has detailed initiatives to expand access to medical education through programs in regions such as India, the United Kingdom, and the United States.
Investors and observers can use this page to monitor conference call announcements, investor conference participation, and governance-related disclosures referenced in press releases. By reviewing these updates, readers gain insight into how Adtalem manages its multi-institution network, responds to healthcare workforce needs, and communicates its strategy and performance to the market.
Tyton Partners (symbol: UTI) announced the election of Max Woolf, Matt Lavelle, and Dan Clary to Partner in its Investment Banking Practice, effective February 25, 2026. The promotions recognize their sector expertise in EdTech, education, workforce and knowledge services and aim to strengthen leadership as the firm grows.
Covista (NYSE:ATGE) unveiled Purpose at Scale, a three-year growth plan to expand healthcare workforce capacity and AI-enabled education.
The company reported 97,000 students (up from ~76,000), 24,000 graduates last year, and provided FY26 guidance of $1.90–$1.94B revenue and $7.80–$8.00 adjusted EPS. Covista also set FY27–FY29 revenue and adjusted EPS growth targets and announced partnerships with GE Healthcare HelloAI and SAIC.
Ross University School of Medicine (NYSE: ATGE) named Cheryl Holmes, M.D., as dean effective March 16, 2026. Holmes brings more than 30 years of clinical and academic experience and will reside in Barbados to integrate with the campus community.
RUSM reported a 96% first-time residency attainment rate for 2024-2025 and produces more M.D.s than any other U.S. medical school with three annual start dates. Interim dean Alejandro Carrasco will move to a Covista vice president role after the transition.
Covista (NYSE:CVSA), formerly Adtalem Global Education (NYSE:ATGE), announced a name and ticker change effective February 24, 2026, after a four-year shift to focus exclusively on healthcare education. The company serves >97,000 students, has 385,000 alumni, and graduates ~24,000 healthcare professionals annually.
Covista released the Covista Care Capacity Monitor with Gallup showing >702,000 monthly healthcare job vacancies, highlighted rural shortages, and will host an Investor Day on February 24 outlining long-term strategy and growth targets. The company also launched Covista Open Doors, a multi-year commitment for scholarships, partnerships, and worker wellbeing programs.
Adtalem Global Education (NYSE: ATGE) reported second quarter fiscal 2026 results with revenue of $503.4 million (up 12.4% YoY) and adjusted EPS of $2.43 (up 34.3% YoY). Total enrollment reached 97,010, marking the tenth consecutive quarter of growth.
The company reported adjusted EBITDA of $154.9 million, completed a $150 million buyback and repurchased $165 million in Q2, and authorized a new $750 million repurchase program. Fiscal 2026 guidance: revenue $1.90–$1.94 billion and adjusted EPS $7.80–$8.00. Investor Day set for Feb. 24, 2026.
Adtalem Global Education (NYSE: ATGE) has been named a "Stock to Study" by BetterInvesting Magazine's Editorial Advisory and Securities Review Committee for the March 2026 issue, signaling the company as worthy of further investor research. The committee highlights consolidated fundamental data—sales, earnings, pre-tax profit, return on equity—available on the Stock Selection Guide for investor review. The March 2026 issue will also feature a fundamental review of Trex Company (NYSE: TREX), identified as potentially undervalued. The committee is composed of CFA charterholders and is chaired by an editor of the magazine. Securities are presented for educational purposes only and are not endorsements; investors are advised to perform their own analysis using the Stock Selection Guide before making decisions.
Adtalem Global Education (NYSE: ATGE) will release second quarter fiscal 2026 results on Wednesday, Jan. 28, 2026 after market close.
The company will host a conference call the same day at 4:00 p.m. CT (5:00 p.m. ET) to discuss results. U.S. dial-in is +1 877-407-6184; international dial-in is +1 201-389-0877; state the prompt "Adtalem earnings call" or use conference ID 13757746. The call will be simulcast and archived on the Adtalem investor relations website with a replay available for 30 days via dial-in or the investor site.
Adtalem (NYSE: ATGE) completed a $150 million accelerated share repurchase, buying ~1.6 million shares, and its Board approved a new $750 million share repurchase authorization through December 2028. Since February 2022 the company has returned $913 million by repurchasing 17.2 million shares at an average price of $52.95, reducing shares outstanding by 30% from the Feb. 1, 2022 base. Adtalem reported 34.9 million shares outstanding as of Dec. 10, 2025 and reduced debt by $1.1 billion to $508.4 million as of Oct. 31, 2025.
The company said repurchases may occur via open market or negotiated transactions, subject to SEC rules and market conditions, and noted an Investor Day on Feb. 24, 2026.
Adtalem Global Education (NYSE: ATGE) said it will accelerate execution of its remaining $136 million under a previously authorized $150 million share repurchase program, with repurchases permitted through May 2028. The company reported Q1 enrollment +8% YoY and Q1 revenue +10.8% YoY, and reaffirmed fiscal year 2026 guidance: revenue $1,900M–$1,940M (≈6.0%–8.5% growth) and adjusted EPS $7.60–$7.90 (≈14.0%–18.5% growth). An Investor Day is scheduled for February 24, 2026.
Summary not available.